Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mead Johnson Labeling On Enfamil Pouches Draws Warning

This article was originally published in The Tan Sheet

Executive Summary

Mead Johnson Nutrition is discussing with FDA whether labeling for Enfamil infant formula marketed in a pouch sufficiently explains safe storage of the product.

You may also be interested in...



FDA Warning On Gerber Formula Claims Strikes Familiar Chord With FTC Complaint

An FDA warning letter to Nestle Infant Nutrition says Gerber Good Start Gentle’s labeling and the product’s website omit or obscure required disclaimers, rendering qualified health claims as unauthorized, and mischaracterize the product’s formulation.

FDA Warning On Gerber Formula Claims Strikes Familiar Chord With FTC Complaint

An FDA warning letter to Nestle Infant Nutrition says Gerber Good Start Gentle’s labeling and the product’s website omit or obscure required disclaimers, rendering qualified health claims as unauthorized, and mischaracterize the product’s formulation.

Abbott Aims To Get Nutritionals Back On Track In Wake Of Similac Recall

Abbott says its nutrition business is on track for a return to full-scale production and growth after absorbing an expected $100 million hit to third-quarter sales from its September Similac recall

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS104645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel